DNP reports today with its ORTEX short score still running at elevated levels — a signal that has built steadily over the past fortnight and remains the defining feature of the pre-earnings setup.
Yesterday's trader note flagged the short score's sharp climb to 61.5 on August 18, up from 44.0 just ten days earlier. That reading has held into the reporting day. The availability data has continued to tighten — dropping from around 366% in early August to 270% now — meaning fewer shares remain available relative to those already borrowed, even if the absolute level still leaves plenty of room before any squeeze pressure materialises. Cost to borrow has stayed flat near 0.81%, confirming that the tightening reflects demand rather than a supply shock. The stock itself has recovered well from a softer week, gaining 11.5% over the past month to PLN 32.49, though it slipped about 2.7% on the week heading into today.
The bull and bear divide centres on whether DNP's expansion-driven model can sustain margin quality as growth costs compound. The ORTEX stock score has climbed to 72 — near its highest reading in three months — led by the fundamentals pillar, where cash flow generation and inventory efficiency have both improved. Forward EPS growth ranks in the 86th percentile of the coverage universe, and the company has consistently beaten estimates, with an EPS surprise factor in the 77th percentile. The valuation picture is less stretched than it looks: a PE near 17x and EV/EBITDA around 10x are both compressing modestly on a 30-day basis. Bears point to the ongoing store rollout absorbing capital and weighing on near-term profitability, a theme reinforced by the March 2026 print, which triggered a 17% one-day drop and a 15% five-day decline. The May 2026 report produced the opposite — a 12.6% single-day gain. Reactions have been binary and large.
Ownership is concentrated. Founder Tomasz Biernacki holds just over 51% of shares, limiting the tradeable float. BlackRock recently added around 1.47 million shares as of end-July, and Capital Research added roughly 1.1 million shares as of August 14 — a sign that international institutional investors have been adding into the recent weakness rather than trimming. Analyst data is now 16 days old, marginally past the freshness threshold, though the consensus mean target of PLN 36.11 implies modest upside from current levels — treat this with some caution given the staleness.
Today's print will test whether DNP's store expansion programme is generating the kind of operating leverage that justifies the recent score improvement and renewed institutional interest, or whether cost pressures are again wider than the market has priced in.
See the live data behind this article on ORTEX.
Open DNP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
